GlassScriptPhysician profile
Geeta Nagpal
NPI 1386838183
$10,853.03
in general payments reported to CMS, 2019-2025
20 companies · $2,612 in 2025
The $2,612 reported for 2025 was more than what 83% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $649 · 2020: $33.99 · 2021: $928 · 2022: $5,468 · 2023: $602 · 2024: $560 · 2025: $2,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,453 · Travel and Lodging: $1,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.59 |
| Travel and Lodging | $1,321.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $3,617.68 | 2021-2022 | |
| Relievant Medsystems, INC. | $1,794.48 | 2022-2023 | Intracept |
| Spinal Simplicity, LLC | $1,524.16 | 2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $1,460.48 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $864.02 | 2019-2025 | Eterna, Proclaim |
| Medtronic USA, INC. | $346.96 | 2019-2020 | |
| Boston Scientific Corporation | $291.23 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Biotronik Nro, INC. | $200.94 | 2025 | Prospera |
| Globus Medical, INC. | $170.65 | 2025 | Senza |
| Stimwave Technologies Incorporated | $145.45 | 2022 | |
| Pacira Therapeutics, INC. | $123.08 | 2019 | |
| Averitas Pharma INC. | $103.87 | 2023-2025 | Qutenza |
| Nevro Corp. | $63.41 | 2023 | Senza |
| Pfizer INC. | $31.03 | 2023 | |
| Ferring Pharmaceuticals INC. | $21.76 | 2023 | Euflexxa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $21.71 | 2025 | Belbuca |
| Nalu Medical, INC. | $21.07 | 2024 | Nalu Neurostimulation System |
| Painteq LLC | $18.87 | 2024 | Painteq |
| Spr Therapeutics, INC | $18.32 | 2025 | Sprint Pns System |
| Teva Pharmaceuticals USA, INC. | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geeta Nagpal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.